We also studied the frequency of other BM-residing cells that have been implicated in tumor context, including hematopoietic stem and progenitor cells (HSPCs), T-cells and B-cells which were detected by expression of cell surface markers CD34/CD45, CD3 and CD19, respectively. This evidence concerns the gene CD34 and neoplasm.